De Novo Status Epilepticus in patients with COVID‐19
Autor: | Shruti P. Agnihotri, Tyler E. Gaston, Sandipan Pati, Alissa Chitlangia, Sana Somani |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Pediatrics medicine.medical_specialty Levetiracetam Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pneumonia Viral Clinical Neurology Neurosciences. Biological psychiatry. Neuropsychiatry Status epilepticus Brief Communication Asymptomatic 03 medical and health sciences Betacoronavirus 0302 clinical medicine Status Epilepticus medicine Humans In patient RC346-429 Pandemics Subclinical infection Aged Retrospective Studies business.industry SARS-CoV-2 General Neuroscience COVID-19 Retrospective cohort study Electroencephalography Middle Aged medicine.disease Black or African American Pneumonia 030104 developmental biology Anticonvulsants Female Neurology (clinical) Neurology. Diseases of the nervous system medicine.symptom business Coronavirus Infections 030217 neurology & neurosurgery RC321-571 |
Zdroj: | Annals of Clinical and Translational Neurology Annals of Clinical and Translational Neurology, Vol 7, Iss 7, Pp 1240-1244 (2020) |
ISSN: | 2328-9503 |
DOI: | 10.1002/acn3.51071 |
Popis: | Neurological complications are increasingly recognized with SARS‐CoV‐2, the causative pathogen for COVID‐19. We present a single‐center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African‐American women with laboratory‐confirmed SARS‐CoV‐2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID‐19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |